Incidence of lipohypertrophy in diabetic patients and a study of influencing factors

Diabetes Research and Clinical Practice

Volumn 77, Issue 2, 2007, Pages 231-236

  Vardar, Bahar ^a   Kizilci, Sevgi ^b  

^a Gözde Hospital   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Insulin management; Lipodystrophy; Lipohypertrophy; Rotation of injection site

Indexed keywords

INSULIN;

ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INJECTION SITE; LIPOHYPERTROPHY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEEDLE; PATIENT CARE; SEX DIFFERENCE; TREATMENT DURATION;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FEMALE; HUMANS; INCIDENCE; INJECTIONS, SUBCUTANEOUS; INSULIN; LIPODYSTROPHY; MALE;

EID: 34247596364     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.12.023     Document Type: Article

References (21)

1. Pek H. On soruda lipodistrofi (2003), Diyabet Hemşireliǧi Derneǧi, İstanbul
2. Kordonouri O., Lauterborn R., and Dei{dotless}ss D. Lipohypertrophy in young patients with Type 1 diabetes. Diab. Care 25 (2002) 634
3. Partanen T., and Rissanen A. Insulin injection practices. Pract. Diab. Int. 17 (2000) 252-254
4. Raile K., Noelle V., and Schawarz H.P. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp. Clin. Endocrinol. Diab. 109 (2001) 393-396
5. McNally P., Jowet N., Kurinczuk J., Peck R., and Hearnshaw J. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulin. Postgrad. Med. 64 (1988) 850-853
6. G. Teft, Lipohypertrophy: patient awareness and implications for practice, January-February/2002, www.findsarticle.com.
7. Hauner H., Haastert B., and Stockamp B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp. Clin. Endocrinol. Diab. 104 (1996) 106-110
8. Strauss K., Gols H., Hannet I., Partanen T.M., and Frid A. A Pan European epidemiologic study of insulin injection technique in patients with diabetes. Pract. Diab. Int. 19 (2002) 71-76
9. Young R., Hannan J., Frier M.B., Steel J.M., and Duncan J.L. Diabetic lipohypertrophy delays insulin absorbtion. Diab. Care 7 (1984) 479-480
10. Strauss K., Gols H., Letondeur C., Matyjaszczyk M., and Frid A. The second injection technique event. Pract. Diab. Int. 19 (2002) 17-21
11. Oktay S., Duma Z., Pek H., Özcan S., Olgun N., Asian H., et al. In: Erdoǧan S. (Ed). Diyabet Hemşireliǧi (2002), Yüce Daǧi{dotless}ti{dotless}m, İstanbul 48-49
12. Nolte M.S. Insulin therapy in insulin dependent diabetes mellitus. Endocrinol. Metab. Clin. N. Am. 21 (1992) 281-305
13. Richardson T., and Kerr D. Skin-related complications of insulin therapy. Am. J. Dermatol. 4 (2003) 661-667
14. Johansson U.B., Amsberg S., Hannerz L., Wredling R., Adamson U., Arnqvist H.J., et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diab. Care 28 (2005) 2025-2027
15. Chowdhury T., and Escudier V. Poor glysemic control caused by insulin induced lipohypertrophy. Br. Med. J. 327 (2003) 383-388
16. Mensing C., Boucher J., Cypress M., Weinger K., Barta P., Hosey G., et al. National standards for diabetes self-management education. Diab. Care 23 (2000) 682-689
17. Grumann J., and Vonkorff M. Self-management services. Dis. Manage Health Outcomes 6 (1999) 151-153
18. Funnel M., and Anderson R.M. Working toward the next generation of diabetes self-management education. Am. J. Prevent. Med. 22 (2002) 3-5
19. Monahan F.D., and Neighbors M. Medical Surgical Nursing (1998), Saunders Company, London pp. 1223-1260
20. Anonymous. Insulin, health modul. Diab. Forecast 58 1 (2005)
21. Puder J.J., Atar M., Muller B., Pavan M., and Keller U. Using insulin pen needles up to five times does not affect needle tip shape nor increase pain intensity. Diab. Res. Clin. Pract. 67 (2005) 119-123